Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
The Pennsylvania State University College of Medicine and The Pennsylvania State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
The Pennsylvania State University College of Medicine and The Pennsylvania State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
Temple University Hospital
mi
from
Philadelphia, PA
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
Methodist Lebonheur Healthcare, UT Lebonheur Pediatric Specialists
mi
from
Memphis, TN
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Methodist Lebonheur Healthcare, UT Lebonheur Pediatric Specialists
mi
from
Memphis, TN
Click here to add this to my saved trials
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
Texas Childrens Hospital. Baylor College of Medicine
mi
from
Houston, TX
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Texas Childrens Hospital. Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
Fletcher Allen Health Care
mi
from
Burlington, VT
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Fletcher Allen Health Care
mi
from
Burlington, VT
Click here to add this to my saved trials
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
University of Virginia Health Systems
mi
from
Charlottesville, VA
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
University of Virginia Health Systems
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
The Cardiovascular Group Centra
mi
from
Lynchburg, VA
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
The Cardiovascular Group Centra
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
Children's Specialty Group PLLC, Children's Hospital of the King's Daughters
mi
from
Norfolk, VA
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Children's Specialty Group PLLC, Children's Hospital of the King's Daughters
mi
from
Norfolk, VA
Click here to add this to my saved trials
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
Univ of Washington
mi
from
Seattle, WA
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
Providence Sacred Heart Medical Center & Children's Hospital
mi
from
Spokane, WA
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Providence Sacred Heart Medical Center & Children's Hospital
mi
from
Spokane, WA
Click here to add this to my saved trials
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Wisconsin, Medical College of Wisconsin Adult Congenital Heart Disease Program
mi
from
Milwaukee, WI
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Wisconsin, Medical College of Wisconsin Adult Congenital Heart Disease Program
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
Ohio State University Medical Center
mi
from
Columbus, OH
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Sciences University
mi
from
Portland, OR
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Sciences University
mi
from
Portland, OR
Click here to add this to my saved trials
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
Barnes-Jewish Hospital/St. Louis Children's Hospital / Washington University School of Medicine
mi
from
Saint Louis, MO
Eisenmenger Quality Enhancement Research Initiative
Eisenmenger Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Barnes-Jewish Hospital/St. Louis Children's Hospital / Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes
ENaC as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
University of New Mexico Hospital; Clinical & Translational Science Center
mi
from
Albuquerque, NM
Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes
ENaC as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
University of New Mexico Hospital; Clinical & Translational Science Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
A Double-Blind Efficacy and Safety Study of the Phosphodiesterase Type 5 Inhibitor Tadalafil in Pediatric Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Children's Heathcare of Atlanta, Inc. at Egleston
mi
from
Atlanta, GA
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
A Double-Blind Efficacy and Safety Study of the Phosphodiesterase Type 5 Inhibitor Tadalafil in Pediatric Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Children's Heathcare of Atlanta, Inc. at Egleston
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
A Double-Blind Efficacy and Safety Study of the Phosphodiesterase Type 5 Inhibitor Tadalafil in Pediatric Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Michigan
mi
from
Detroit, MI
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
A Double-Blind Efficacy and Safety Study of the Phosphodiesterase Type 5 Inhibitor Tadalafil in Pediatric Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Michigan
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
A Double-Blind Efficacy and Safety Study of the Phosphodiesterase Type 5 Inhibitor Tadalafil in Pediatric Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
A Double-Blind Efficacy and Safety Study of the Phosphodiesterase Type 5 Inhibitor Tadalafil in Pediatric Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
A Double-Blind Efficacy and Safety Study of the Phosphodiesterase Type 5 Inhibitor Tadalafil in Pediatric Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Vanderbilt Univeristy School of Medicine
mi
from
Nashville, TN
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
A Double-Blind Efficacy and Safety Study of the Phosphodiesterase Type 5 Inhibitor Tadalafil in Pediatric Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Vanderbilt Univeristy School of Medicine
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
A Double-Blind Efficacy and Safety Study of the Phosphodiesterase Type 5 Inhibitor Tadalafil in Pediatric Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Texas Children's Hospital
mi
from
Houston, TX
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
A Double-Blind Efficacy and Safety Study of the Phosphodiesterase Type 5 Inhibitor Tadalafil in Pediatric Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
A Double-Blind Efficacy and Safety Study of the Phosphodiesterase Type 5 Inhibitor Tadalafil in Pediatric Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Primary Children's Medical Center
mi
from
Salt Lake City, UT
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
A Double-Blind Efficacy and Safety Study of the Phosphodiesterase Type 5 Inhibitor Tadalafil in Pediatric Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
A Double-Blind Efficacy and Safety Study of the Phosphodiesterase Type 5 Inhibitor Tadalafil in Pediatric Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
A Double-Blind Efficacy and Safety Study of the Phosphodiesterase Type 5 Inhibitor Tadalafil in Pediatric Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
A Double-Blind Efficacy and Safety Study of the Phosphodiesterase Type 5 Inhibitor Tadalafil in Pediatric Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
AKH
mi
from
Wien,
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
A Double-Blind Efficacy and Safety Study of the Phosphodiesterase Type 5 Inhibitor Tadalafil in Pediatric Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
AKH
mi
from
Wien,
Click here to add this to my saved trials
Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD)
Simultaneous Risk Factor Control Using Telehealth to SlOw Progression of Diabetic Kidney Disease (STOP-DKD)
Status: Enrolling
Updated:  12/31/1969
Duke University Health System Clinics
mi
from
Durham, NC
Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD)
Simultaneous Risk Factor Control Using Telehealth to SlOw Progression of Diabetic Kidney Disease (STOP-DKD)
Status: Enrolling
Updated: 12/31/1969
Duke University Health System Clinics
mi
from
Durham, NC
Click here to add this to my saved trials
Premature Ventricular Contractions (PVCs) and Blood Pressure Control
The Effects of PVC Suppression on Blood Pressure Control in Patients With Frequent PVCs
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin
mi
from
Madison, WI
Premature Ventricular Contractions (PVCs) and Blood Pressure Control
The Effects of PVC Suppression on Blood Pressure Control in Patients With Frequent PVCs
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure
Status: Enrolling
Updated:  12/31/1969
Washington DC VA Medical Center
mi
from
Washington,
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure
Status: Enrolling
Updated: 12/31/1969
Washington DC VA Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic
mi
from
Jacksonville, FL
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure
Status: Enrolling
Updated:  12/31/1969
Carolinas Medical Center
mi
from
Charlotte, NC
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure
Status: Enrolling
Updated: 12/31/1969
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure
Status: Enrolling
Updated:  12/31/1969
Louis Stokes Cleveland VA Medical Center
mi
from
Cleveland, OH
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure
Status: Enrolling
Updated: 12/31/1969
Louis Stokes Cleveland VA Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure
Status: Enrolling
Updated:  12/31/1969
Memphis VA
mi
from
Memphis, TN
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure
Status: Enrolling
Updated: 12/31/1969
Memphis VA
mi
from
Memphis, TN
Click here to add this to my saved trials
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure
Status: Enrolling
Updated:  12/31/1969
Houston VA
mi
from
Houston, TX
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure
Status: Enrolling
Updated: 12/31/1969
Houston VA
mi
from
Houston, TX
Click here to add this to my saved trials
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Targeting the Right Ventricle in Pulmonary Hypertension
A Randomized, Double-blind, Placebo Controlled, Multi-center Study to Assess the Effect of Ranolazine on Outcomes in Subjects With Pulmonary Hypertension and Right Ventricular Dysfunction Accompanied by a Comparative Study of Cellular Metabolism in Subjects With Pulmonary Hypertension With and Without Right Ventricular Dysfunction
Status: Enrolling
Updated:  12/31/1969
University of Maryland
mi
from
Baltimore, MD
Targeting the Right Ventricle in Pulmonary Hypertension
A Randomized, Double-blind, Placebo Controlled, Multi-center Study to Assess the Effect of Ranolazine on Outcomes in Subjects With Pulmonary Hypertension and Right Ventricular Dysfunction Accompanied by a Comparative Study of Cellular Metabolism in Subjects With Pulmonary Hypertension With and Without Right Ventricular Dysfunction
Status: Enrolling
Updated: 12/31/1969
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Targeting the Right Ventricle in Pulmonary Hypertension
A Randomized, Double-blind, Placebo Controlled, Multi-center Study to Assess the Effect of Ranolazine on Outcomes in Subjects With Pulmonary Hypertension and Right Ventricular Dysfunction Accompanied by a Comparative Study of Cellular Metabolism in Subjects With Pulmonary Hypertension With and Without Right Ventricular Dysfunction
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Targeting the Right Ventricle in Pulmonary Hypertension
A Randomized, Double-blind, Placebo Controlled, Multi-center Study to Assess the Effect of Ranolazine on Outcomes in Subjects With Pulmonary Hypertension and Right Ventricular Dysfunction Accompanied by a Comparative Study of Cellular Metabolism in Subjects With Pulmonary Hypertension With and Without Right Ventricular Dysfunction
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Targeting the Right Ventricle in Pulmonary Hypertension
A Randomized, Double-blind, Placebo Controlled, Multi-center Study to Assess the Effect of Ranolazine on Outcomes in Subjects With Pulmonary Hypertension and Right Ventricular Dysfunction Accompanied by a Comparative Study of Cellular Metabolism in Subjects With Pulmonary Hypertension With and Without Right Ventricular Dysfunction
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Targeting the Right Ventricle in Pulmonary Hypertension
A Randomized, Double-blind, Placebo Controlled, Multi-center Study to Assess the Effect of Ranolazine on Outcomes in Subjects With Pulmonary Hypertension and Right Ventricular Dysfunction Accompanied by a Comparative Study of Cellular Metabolism in Subjects With Pulmonary Hypertension With and Without Right Ventricular Dysfunction
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
Status: Enrolling
Updated:  12/31/1969
Cardiovascular Associates of the Southeast, LLC
mi
from
Birmingham, AL
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
Status: Enrolling
Updated: 12/31/1969
Cardiovascular Associates of the Southeast, LLC
mi
from
Birmingham, AL
Click here to add this to my saved trials
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic
mi
from
Phoenix, AZ
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
Status: Enrolling
Updated:  12/31/1969
Pulmonary Associates, PA
mi
from
Phoenix, AZ
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
Status: Enrolling
Updated: 12/31/1969
Pulmonary Associates, PA
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center
mi
from
Beverly Hills, CA
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
Status: Enrolling
Updated:  12/31/1969
UCSF-Fresno
mi
from
Fresno, CA
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
Status: Enrolling
Updated: 12/31/1969
UCSF-Fresno
mi
from
Fresno, CA
Click here to add this to my saved trials
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
Status: Enrolling
Updated:  12/31/1969
UCSD Medical Center, Pulmonary Department
mi
from
La Jolla, CA
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
Status: Enrolling
Updated: 12/31/1969
UCSD Medical Center, Pulmonary Department
mi
from
La Jolla, CA
Click here to add this to my saved trials
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
Status: Enrolling
Updated:  12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
Status: Enrolling
Updated:  12/31/1969
VAGLAHS, VA Greater LA Healthcare System
mi
from
Los Angeles, CA
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
Status: Enrolling
Updated: 12/31/1969
VAGLAHS, VA Greater LA Healthcare System
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
Status: Enrolling
Updated:  12/31/1969
University of California, San Francisco Medical Center
mi
from
San Francisco, CA
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
Status: Enrolling
Updated: 12/31/1969
University of California, San Francisco Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials